Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia

Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia

Bayer, a leading global life sciences company, and Huma Therapeutics Limited ("Huma"), a leading global digital health company, today announced the launch of their innovative heart health screening tool in Saudi Arabia. This marks the first global launch since the Bayer Aspirin Heart Health Risk Assessment went live in the US in 2023, and is aimed at supporting key objectives of the Vision 2030 Bayer Expands Partnership with Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia